Shelton David C 4
4 · Chemours Co · Filed May 9, 2022
Insider Transaction Report
Form 4
Shelton David C
GC, Corp. Secretary & SVP
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-05-05−67,736→ 33,868 totalExercise: $14.43Exp: 2030-03-02→ Common Stock (67,736 underlying) - Exercise/Conversion
Common Stock
2022-05-05$5.40/sh+83,044$448,438→ 134,169.116 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-05−83,044→ 0 totalExercise: $5.40Exp: 2026-03-01→ Common Stock (83,044 underlying) - Sale
Common Stock
2022-05-05$39.99/sh−83,044$3,320,930→ 51,125.116 total - Sale
Common Stock
2022-05-05$39.99/sh−67,736$2,708,763→ 51,125.116 total - Exercise/Conversion
Common Stock
2022-05-05$14.43/sh+67,736$977,430→ 118,861.116 total
Holdings
- 91,992(indirect: By GRAT)
Common Stock
Footnotes (4)
- [F1]Includes directly owned shares, restricted stock units, and dividend equivalent units.
- [F2]Shares were sold in multiple transactions at prices ranging from $39.68 to $40.47.
- [F3]Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017.
- [F4]Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.